| |
PRODUCTS, SERVICES
Pharmaceuticals
Gene, Stem Cell Therapy, Antisense, Human Clinical Trials
Stem Cell Genetic Treatment Research
human gene therapy research clinical trials, cystic fibrosis gene therapy, alzheimers gene therapy, diabetes gene therapy, hemophilia gene therapy, cancer treatment gene therapy
|
 |
Showing 1-15
of 15
 = product catalog / search specs
|
|
|
Antisense Pharma - Malignant Glioma Cancer Tumor Targeted Therapy Clinical Trial Research , Private Ownership
Regensburg Germany 49 941 9201 30 |
|
|
Antisense Therapeutics Ltd - Multiple Sclerosis Gene Therapy Clinical Trial, Asthma, Sight Disorder, Stock Symbol ANP (Australia)
Toorak, Victoria Australia 61 3 9827 8999 |
|
|
Avecia - Oligo Biotechnology Contract Pharmaceutical Development GMP Protein Biologics Manufacturing, Private Ownership
Blackley, Manchester UK 44 161 721 2446 |
|
Avecia oligo-medicines $110 Million US Dollar sales, cGMP peptide solid phase synthesis. Avecia Biologics cGMP contract manufacturing services pharmaceutical microbial mammalian based therapeutics, vaccines, cytokines, growth factors, cell banking
|
BioE Inc - Human Progenitor Stem Cells, Umbilical Cord Blood Processing Activation Reagents, Private Ownership
White Bear Lake, MN USA 651 426 6466 |
|
|
Enzo Biochem - RNA Nucleic Acid Labeling, Ribonucleotides, Deoxynucleotides, in-Situ Hybridization, Stock Symbol ENZ
Farmingdale, NY USA 631 694 7070 |
|
Enzo Biochem $85 Million sales, nucleotides, RNA transcript labeling kit gene expression reagents, spotted microarray labeling, monoclonal antibodies, RNA amplification, RNA transcript labeling kits, apoptosis assay, HPV assay, signal generating kits
|
Geron Corp - Biopharmaceutical Oncology Therapeutic Development, Stem Cell Therapy, Stock Symbol GERN
Menlo Park, CA USA 650 473 7700 |
|
|
Osiris Therapeutics Inc - Adult Bone Marrow Stem Cell Therapy Research, Crohns, GVHD, Heart Attacks, Stock Symbol OSIR
Columbia, MD USA 443 545 1800 |
|
Osiris Therapeutics Inc $1.4 Billion Genzyme stem cell collaboration agreement November 2008
|
Oxford Biomedica - Gene Therapy Research, Gene Based Therapeutics, Stock Symbol OXB.L (London)
Oxford UK 44 1865 783 000 |
|
|
Selective Genetics Inc - Gene Therapeutics, Diabetic Foot Wound Treatment Clinical Trials, Private Ownership
San Diego, CA USA 858 793 6641 |
|
|
Stem Cells Inc (Stemcells) - Therapeutic Stem Cells, Neurodegenerative Batten Clinical Trials, Stock Symbol STEM
Palo Alto, CA USA 650 475 3100 |
|
|
Takara - Bio - DNA Microarray, PCR kits, DNA Polymerase, Restriction Endonuclease, Real Time PCR, Stock Symbol 2531 (Tokyo)
Otsu Shiga, Japan 81.77.543.7200 |
|
Takara Bio PCR DNA polymerase enzymes, real time PCR probes, nucleic acid primers, vectors, markers, mRNA interferase, DNA purification kit, adenovirus expression kit, retrovirus vector, PCR thermal Cycler, Electrophoresis, gene therapy
|
Targeted Genetics - Molecular Gene Therapy, Arthritis Clinical Program, AIDS Vaccine Development, Stock Symbol TGEN
Seattle, WA USA 206 623 7612 |
|
|
Tekmira Pharmaceuticals - Protiva Biotherapeutics - RNAi Interference Therapeutics Research , Stock Symbol TKM (Toronto, Canada)
Burnaby, BC Canada 604 419 3200 |
|
|
TheraCyte Inc - Gene Therapy Implant Systems Cell Transplantation Protein Delivery, Immunotherapy , Private Ownership
Laguna Hills, CA USA 949 280 9211 |
|
|
Vitro Diagnostics Inc - Human Adult Stem Cell Lines, Diabetes Research Treatment, Private Ownership
Aurora, CO USA 720 859 4120 |
|
|
| Showing 1-15
of 15
|
|
